EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Global epidemiology of hepatitis B virus infection in dialysis patients: a systematic review and meta-analysis of prevalence, immunity, risk factors, and beyond

Alif Hasan Pranto, Ehsan Suez, Md Ekhtiar Uddin, Hasan Shahriyer Tonmoy, M M Rubaiyat Muntasir Meem, Fahim Montasir, Farzana Nourin, Farhana Ahmed, Shifaty Nur Abir, Dewan Zubaer Islam, Muhammed Ajmal, Rahima Begum und 1 weitere

International Urology and Nephrology · 25.03.2026 · 58 (10) · 4253-4278

DOI: 10.1007/s11255-026-05112-5 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Urology and Nephrology, online erschienen am 25.03.2026. Verfasst von Alif Hasan Pranto und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, BRAC University, Dhaka, 1212, Bangladesh. Hauptthemen laut MEDLINE: Renal Dialysis, Hepatitis B. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 163 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B infection is a global threat caused by the Hepatitis B virus (HBV), which can be transmitted through blood transfusions. Again, dialysis is a mechanical process that is used to filter the blood of patients with chronic kidney disease (CKD). In this study, we aimed to evaluate the worldwide prevalence of HBV infection using primary published data on hepatitis B virus surface antigen (HBsAg) and HBV-DNA prevalence among dialysis patients. To obtain the data, we searched three different online databases, and from 479 studies, 79 articles were selected for this study. Besides prevalence analysis, study outliers, quality, and characteristics were identified as well. We found the pooled prevalence of HBsAg and HBV-DNA to be 7.0% (95%CI: 6.1-8.0) and 1.5% (95%CI: 1.0-1.9), respectively, although, excluding the outliers, the prevalence of HBsAg became 6.3%, but HBV-DNA remained the same. Besides, we determined that 49.2% (95%CI: 30.2-68.1) of dialysis patients took the HBV vaccine, and 40.0% (95%CI: 31.1-48.8) of patients developed natural immunity (anti-HBV antibody). Among continent-based analyses, Australia was determined to have the highest prevalence of HBsAg (8.7%), and Asia and Africa were found to have the same and highest prevalence of HBV-DNA (4.1%). Among risk factors, blood transfusion was the highest, followed by duration of dialysis, HCV/other infections, renal diseases, and so on. This study indicates the importance of careful and contamination risk-free dialysis among patients, vaccination, and early diagnosis of HBV to avoid and prevent the risk of HBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisHepatitis BHumansPrevalenceRisk FactorsGlobal HealthHepatitis B Surface AntigensDNA, ViralHepatitis B virus

Stichwörter der Autor:innen

CKDDialysisHBVHepatitisKidneyPrevalence

Substanzen

Hepatitis B Surface AntigensDNA, Viral

Autor:innen und Institutionen

  • School of Pharmacy, BRAC University, Dhaka, 1212, Bangladesh.
  • Institute of Bioinformatics, University of Georgia, Athens, GA, 30602, USA.
  • The School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
  • Department of Pharmaceutical Sciences, School of Health and Life Sciences, North South University, Dhaka, 1229, Bangladesh.
  • Faculty of Medical Sciences, Bangladesh University of Professionals, Dhaka, 1216, Bangladesh.
  • School of Human Science, London Metropolitan University, Holloway Road, London, N7 8DB, UK.

Zitieren

APA

Pranto, A. H., Suez, E., Uddin, M. E., Tonmoy, H. S., Meem, M. M. R. M., Montasir, F., Nourin, F., Ahmed, F., Abir, S. N., Islam, D. Z., Ajmal, M., Begum, R., & Khandker, S. S. (2026). Global epidemiology of hepatitis B virus infection in dialysis patients: a systematic review and meta-analysis of prevalence, immunity, risk factors, and beyond. International Urology and Nephrology, 58(10), 4253-4278. https://doi.org/10.1007/s11255-026-05112-5

Vancouver

Pranto AH, Suez E, Uddin ME, Tonmoy HS, Meem MMRM, Montasir F, et al. Global epidemiology of hepatitis B virus infection in dialysis patients: a systematic review and meta-analysis of prevalence, immunity, risk factors, and beyond. International Urology and Nephrology. 2026;58(10):4253-4278. doi:10.1007/s11255-026-05112-5

BibTeX
@article{Pranto2026,
  author = {Pranto, Alif Hasan and Suez, Ehsan and Uddin, Md Ekhtiar and Tonmoy, Hasan Shahriyer and Meem, M M Rubaiyat Muntasir and Montasir, Fahim and Nourin, Farzana and Ahmed, Farhana and Abir, Shifaty Nur and Islam, Dewan Zubaer and Ajmal, Muhammed and Begum, Rahima and Khandker, Shahad Saif},
  title = {Global epidemiology of hepatitis B virus infection in dialysis patients: a systematic review and meta-analysis of prevalence, immunity, risk factors, and beyond},
  journal = {International Urology and Nephrology},
  year = {2026},
  volume = {58},
  number = {10},
  pages = {4253--4278},
  doi = {10.1007/s11255-026-05112-5}
}
Kostenlos starten →